ARIAD Pharmaceuticals Inc (ARIA.OQ)
20 Jan 2017
Jan 10 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:
* If deal is terminated by co, to enter definitive agreement with respect to superior proposal, co to pay termination fee of $169 million Source text - http://bit.ly/2ido9QF Further company coverage:
Jan 10 The following bids, mergers, acquisitions and disposals were reported by 1100 GMT on Tuesday:
TOKYO Japan's Takeda Pharmaceutical Co flagged its appetite for fresh acquisitions to bolster its drug portfolio after agreeing on Monday to acquire cancer drug maker Ariad Pharmaceuticals in a $5.20 billion deal.
* Takeda able to limit debt, retain credit rating post Ariad deal-CFO
TOKYO, Jan 10 Japan's Takeda Pharmaceutical Co Ltd expects annual sales from new lung cancer drug brigatinib, added to its portfolio with the acquisition of Ariad Pharmaceuticals Inc, will exceed $1 billion, the Japanese company's CEO said on Tuesday.
* Health sector gains on string of multi-billion dollar deals
Japan's Takeda Pharmaceutical Co Ltd said it would buy cancer drug maker Ariad Pharmaceuticals Inc in a deal valued at $5.20 billion, to beef up its oncology pipeline.
Jan 9 Japan's Takeda Pharmaceutical Co Ltd said it would buy cancer drug maker Ariad Pharmaceuticals Inc in a deal valued at $5.20 billion, to beef up its oncology pipeline.
* Ariad Pharmaceuticals Inc - Deal for $24.00 per share in cash, or an enterprise value of approximately $5.2 billion
|Takeda Pharmaceutical Co Ltd (4502.T)||¥4,707||-7.00|
|Astellas Pharma Inc (4503.T)||¥1,530||-13.50|
|CHUGAI PHARMACEUTICAL CO., LTD. (4519.T)||¥3,350||-60.00|
|Johnson & Johnson (JNJ.N)||$114.15||-0.05|
|Pfizer Inc. (PFE.N)||$31.77||+0.07|
|Novartis AG (NOVN.S)||CHF70.90||--|
|Merck & Co., Inc. (MRK.N)||$62.53||+2.20|
|Roche Holding Ltd. (ROG.S)||CHF233.50||--|
|Roche Holding Ltd. (RO.S)||CHF236.10||--|
|Sanofi SA (SASY.PA)||€75.62||--|